Medical/Pharmaceuticals
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma
SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...
2024-07-16 19:29
2122
Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma
SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...
2024-07-16 17:10
2328
WIPO Honours Vivo Surgical with Global Accolade for Innovation and IP Excellence
Pioneering Singaporean surgical robotics company selected from over 660 applicants worldwide to emerge as a winner of the coveted WIPO Global Awards for 2024 GENEVA, July 16, 2024 /PRNewswire/ -- Vivo Surgical, a privately-held medical technology company pioneering a flexible endoscopic robot fo...
2024-07-16 16:45
15196
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC
SHANGHAI, July 15, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been approved by the NMPA to enter Phase II clinical trial as monotherapy or in combination with a PD...
2024-07-15 22:00
1837
In Honor of World Brain Day, the World Federation of Neurology to Host Free Public Webinar to Spotlight Brain Health and Disease Prevention
LONDON, July 15, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN)
is hosting its 11th annual World Brain Day on July 22. This year, World Brain
Day will unite neurologists, patients, advocates and educators all over the
world under the theme "Brain Health and Prevention."
2024-07-15 20:30
2660
United Imaging Announces First PET/CT Installation in Mexico, at Instituto Nacional de Pediatría
MEXICO CITY, July 15, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has launched its uMI 550 PET/CT system at the Instituto Nacional de Pediatría (INP) inMexico. This partnership reflects a shared commitment between the two organizati...
2024-07-15 20:00
1157
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll
Biopharma (KRX: 009420.KS) announced today the appointment ofChristopher W.
Slavinsky as Chief Business Development and Legal Officer.
2024-07-15 19:00
1613
CooperVision Champions Children's Eye Health at WCPOS V 2024
Global Myopia Management Leader Showcases Long-Term Benefits of MiSight® 1 day
KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- CooperVision
2024-07-15 14:00
8117
CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area
SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...
2024-07-15 13:59
1776
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis
SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...
2024-07-15 13:44
1854
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1
SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...
2024-07-15 12:17
3222
Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy
CAMBRIDGE, Mass., July 14, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a collaboration a...
2024-07-15 10:12
1216
Physta® Tongkat Ali: Breakthrough Antiviral Study Reinforces Immune-Boosting & Healthy Ageing Benefits
KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- In a significant breakthrough for the nutraceutical industry, Physta® Tongkat Ali, a proprietary extract of the traditional herbEurycoma longifolia from Biotropics Malaysia, has been spotlighted in a recently published study for its potent ant...
2024-07-15 08:00
7741
Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule
CHENGDU, China, July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced that onJuly 10, 2024, NASDAQ notified the Company that it has determined that for the...
2024-07-12 20:30
6170
Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress
TAIPEI and SAN DIEGO, July 12, 2024 /PRNewswire/ -- Senhwa Biosciences' new drug Pidnarulex (CX-5461) has demonstrated efficacy in treating various solid tumors with BRCA2 or PALB2 gene defects. The abstract of this clinical trial has been selected for presentation at the 2024 European Society fo...
2024-07-12 19:00
4412
Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in Diabetes Management
SHENZHEN, China, July 12, 2024 /PRNewswire/ -- On July 5th, the 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx), led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and DTx Digital Therapeutics R&D Center ("R&D Center"), co-sponsored by She...
2024-07-12 17:09
3835
MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024
BANGKOK, July 12, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024...
2024-07-12 16:57
3404
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 12, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, an...
2024-07-12 16:53
4281
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE
BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it plans to change the ratio of its American d...
2024-07-12 04:00
3817
Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation
SEOUL, South Korea, July 11, 2024 /PRNewswire/ -- Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointedHan Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including ...
2024-07-11 21:00
2421
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5608
